Animal models of choroidal and retinal neovascularization

Progress in Retinal and Eye Research

Volumn 29, Issue 6, 2010, Pages 500-519

  Grossniklaus, Hans E ^a   Kang, Shin J ^a   Berglin, Lennart ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

Animal models; Choroidal neovascularization; Retinal neovascularization

Indexed keywords

ANGIOGENESIS INHIBITOR; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; COLLAGENASE; DEXAMETHASONE; DEXTRAN; DOXYCYCLINE; GENE THERAPY AGENT; HYALURONIDASE; HYDROPEROXIDE DERIVATIVE; INTEGRIN INHIBITOR; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; NANOPARTICLE; NITROGEN; OXYGEN; RHODOPSIN; STREPTOZOCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 164;

ANGIOGENESIS; ANIMAL MODEL; BORDETELLA PERTUSSIS; BRUCH MEMBRANE; CHROMOSOME MUTATION; CLINICAL TRIAL; DIABETIC RETINOPATHY; DIODE LASER; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG MECHANISM; EXPERIMENTAL MODEL; EXPERIMENTAL STUDY; EYE FUNDUS; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INJECTION; INTERMETHOD COMPARISON; KITTEN; KNOCKOUT MOUSE; LASER COAGULATION; LIGHT; MONKEY; MOUSE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OXIDATIVE STRESS; OXYGEN BLOOD LEVEL; PATHOGENESIS; PATHOLOGY; PHOTODYNAMIC THERAPY; PIGMENT CELL; PRIMATE; PRIORITY JOURNAL; PROMOTER REGION; RABBIT; RADIATION; RAT; RETINA BLOOD VESSEL; RETINA BLOOD VESSEL OCCLUSION; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA NEOVASCULARIZATION; RETINA RADIATION TRAUMA; RETINOPATHY; REVIEW; SPECTRAL SENSITIVITY; SUBRETINAL NEOVASCULARIZATION; SURGICAL TECHNIQUE; SWINE; TRANSGENIC MOUSE; ZEBRA FISH;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; HUMANS; RETINAL NEOVASCULARIZATION;

EID: 78650222440     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2010.05.003     Document Type: Review

References (141)

1. Aguilar E., Dorrell M.I., Friedlander D., Jacobson R.A., Johnson A., Marchetti V., Moreno S.K., Ritter M.R., Friedlander M. Ocular models of angiogenesis. Methods Enzymol. 2008, 444:115-158.
2. Albert D.M., Neekhar A., Wang S., Darjatmoko S.R., Sorenson C.M., Subielzig R.R., Sheibani N. Development of choroidal neovascularizaiton in rats with advanced intense cyclic light-induced retinal degeneration. Arch. Ophthalmol. 2010, 128:212-222.
3. Ambati J., Anand A., Fernandez S., et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2- deficient mice. Nat. Med. 2003, 11:1290-1397.
4. Amin R., Pucklin J.E., et al. Growth factor localization in choroidal noevascular membranes of age-related macular degeneration. Inv Ophthalmol. Vis. Sci. 1994, 35:3178-3188.
5. Antoszyk A.N., Gottlieb J.L., Machemer R., Hatchell D.L. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefes Arch. Clin. Exp. Ophthalmol. 1993, 231:34-40.
6. Ashton N. Retinal vascularization in health and disease. Am. J. Ophthalmol. 1957, 44:7-17.
7. Ashton N. Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies. The XX Francis I. Proctor lecture. Am. J. Ophthalmol. 1966, 62:412-435.
8. Ashton N., Ward B., Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br. J. Ophthalmol. 1954, 38:397-432.
9. Baffi J., Byrnes G., Chan C.C., Csaky K.G. Choroidal neovascularization in the rat induced by adenovirus mediate expression of vascular endothelial growth factor. Inv Ophthalmol. Vis. Sci. 2000, 41:3582-3589.
10. Bai Y., Ma J.X., Guo J., Wang J., Zhu M., Chen Y., Le Y.Z. Müller cell-derived VEGF is a significant contributor to retinal neovascularization. J. Pathol. 2009, 219:446-454.
11. Bainbridge J.W., Mistry A.R., Thrasher A.J., Ali R.R. Gene therapy for ocular angiogenesis. Clin. Sci. (Lond.) 2003, 104:561-575.
12. Baird P.N., Robman L.D., Richardson A.J., et al. Gene environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection. Hum. Mol. Genet. 2008, 17:1299-1305.
13. Bein K., Simons M. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J. Biol. Chem. 2000, 275:32167-32173.
14. Bek T. Glial cell involvement in vascular occlusion of diabetic retinopathy. Acta Ophthalmol. Scand. 1997, 75:239-243.
15. Bergers G., Brekken R., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2000, 2:737-744.
16. Berglin L., Sarman S., gan der Ploeg I., et al. Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2 deficient mice. Inv Ophthalmol. Vis. Sci. 2003, 44:403-408.
17. Bora P.S., Sohn J.G., Curz J.M., et al. role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J. Immunol. 2005, 174:491-497.
18. Bora P.S., Hu Z., Tezel T.H., Sohn J.H., Kang S.G., Cruz J.M., boar N.S., Garen A., Kaplan H.J. Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. PNAS 2003, 100:2679-2684.
19. Campochiaro P.A. Retinal and choroidal neovascularization. J. Cell Physiol. 2000, 184:301-310.
20. Cao R., Jensen L., Söll I., Hauptmann G., Cao Y. Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy. PLoS ONE 2008, 3:e2748.
21. Cao Y. Endogenous angiogenesis inhibitors and their therapeutic implications. Int. J. Biochem. Cell Biol. 2001, 33:357-369.
22. Carmeliet P., Collen D. Tissue factor. Int. J. Biochem. Cell Biol. 1998, 30:661-667.
23. Chan C.C., Caspi R.R., Ni M., Leake W.C., Wiggert B., Chader G.J., Nussenblatt R.B. Pathology of experimental autoimmunity in mice. J. Autoimmun. 1990, 3:247-255.
24. Chan C.C., Ross R.J., Shen D., et al. Cl2/C×3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthamic Res. 2008, 40:124-128.
25. Chan-Ling T., Tout S., Holländer H., Stone J. Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 1992, 33:2128-2147.
26. Criswell M.H., Ciulla T.A., Hill T.E., et al. The squirrel monkey: characterization of a new-world primate model of experimental choroidal neovascularization and comparison with the macaque. Inv Ophthalmol. Vis. Sci. 2004, 45:625-634.
27. Cui J.Z., Kimura H., Spee C., et al. Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate. Graefe's Arch. Clin. Exp. Ophthlamol 2000, 238:326-333.
28. Danis R., Yang Y., Massicotte S., Boldt C. Preretinal and optic nerve head neovascularization induced by photodynamic venous thrombosis in domestic pigs. Arch. Ophthalmol. 1993, 111:539-543.
29. Dithmar S., Curcio C.A., Le N.A., et al. Ultrastructural changes in Bruchs membrane of apoplipoprotein E-deficient mice. Inv Ophthalol Vis. Sci. 2000, 41:2035-2042.
30. Dobi E.T., Puliafito C.A., Destro M. A new model of experimental choroidal neovascularization in the rat. Arch. Ophthalmol. 1989, 107:264-269.
31. El Diniri A.A., Ogden T.E., Ryan S.J. Subretinal endophotocoagulation. A new model of subretinal neovascularization in the rabbit. Retina 1991, 11:244-249.
32. Elner V.M., Streiten R.M., Elner S.G., et al. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am. J. Pathol. 1996, 136:745-750.
33. Espinosa-Heidmann D.G., Suner I., Hernandez E.P., et al. Age as an independent risk factor for severity of experimental choroidal neovascularization. Inv Ophthalmol. Vis. Sci. 2002, 43:1567-1573.
34. Espinosa-Heidmann D.G., Suner I., Hernandez E.P., et al. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Inv Ophthalmol. Vis. Sci. 2003, 44:3586-3592.
35. Feit-Leichman R.A., Kinouchi R., Takeda M., Fan Z., Mohr S., Kern T.S., Chen D.F. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest. Ophthalmol. Vis. Sci. 2005, 46:4281-4287.
36. Ferguson T., Apte R.S. Angiogenesis in eye disease: immunity gained or immunity lost?. Semin. Immunopathol 2008, 30:111-119.
37. Folkman J., D'Amore P.A., et al. Blood vessel formation: what is its molecular basis?. Cell 1996, 87:1153-1155.
38. Frank R.N., Das A., Weber M.L. A model of subretinal neovascularization in the pigmented rat. Curr. Eye Res. 1989, 8:239-247.
39. Gale N.W., Yancopoulos G.D. Growth factors activing via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999, 13:1055-1066.
40. Green W.R. The uveal tract. Ophthalmic Pathology: An Atlas and Textbook 2006, 1597-1607. WB Saunders, Philadelphia. W.R. Spencer (Ed.).
41. Green W.R., Wilson D.J. Choroidal neovascularization. Ophthalmology 1986, 93:169-1176.
42. Greenberg J.I., Shields D.J., Barillas S.G., et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008, 456:809-813.
43. Grossniklaus H.E., Cingle K.A., Yoon Y.D., Ketkar N., L'Hernault N., Brown S. Correlation of histologic 2-dimensional reconstruction and confocal scanning laser microscopic imaging of choroidal neovascularization in eyes with age-related maculopathy. Arch. Ophthalmol. 2000, 118:625-629.
44. Grossniklaus H.E., Green W.R. Choroidal neovascularization. Am. J. Ophthalmol. 2004, 137:496-503.
45. Grossniklaus H.E., Ling J.X., Wallace T.M., et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis. 2002, 8:119-126.
46. Hageman G.S., Luthert P.J., et al. An integrated hypothesis that considers drusen as biomarkers of immune-meidated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retina Eye Res. 2001, 20:705-732.
47. Hahn P., Qian Y., Dentchev T., et al. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. PNAS 2004, 101:13850-13855.
48. Ham D.I., Chang K., Chung H. Preretinal neovascularization induced by experimental retinal vein occlusion in albino rats. Korean J. Ophthalmol. 1997, 11:60-64.
49. Heckenlively J.R., Hawes N.L., Friedlander M., Nusinowitz S., Hurd R., Davisson M., Chang B. Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 2003, 23:518-522.
50. Hellstrom A., Perruzzi C., Ju M., Engstrom E., Hard A.L., Liu J.L., Albersson-Wikland K., Carlsson B., Niklasson A., Sjodell L., LeRoith D., Senger D.R., et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc. Natl. Acad. Sci. USA 2001, 98:5804-5808.
51. Holash J., Maisonpierre P.C., et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 2841994-2841998.
52. Hollyfield J.G., Bonilha V.L., Rayborn M.E., et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 2008, 14:194-198.
53. Holmes J.M., Duffner L.A. The effect of postnatal growth retardation on abnormal neovascularization in the oxygen exposed neonatal rat. Curr. Eye Res. 1996, 15:403-409.
54. Holmes J.M., Zhang S., Leske D.A., Lanier W.L. The effect of carbon dioxide on oxygen-induced retinopathy in the neonatal rat. Curr. Eye Res. 1997, 16:725-732.
55. Hsu H.T., Goodnight R., Ryan S.J. Subretinal choroidal neovascularization as a response to penetrating retinal injury in the pigmented rabbit. Jpn. J. Ophthalmol. 1989, 33:358-366.
56. Imamura Y., Noda S., Hashizume K., Shinoda K., Yamaguchi M., Uchiyama S., Shimizu T., Mizushima Y., Shirasawa T., Tsuboto K. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age prelated macular degeneration. PNAS 2006, 103:11282-11287.
57. Irvine A.R., Wood I.S. Radiation retinopathy as an experimental model for ischemic proliferative retinopathy and rubeosis iridis. Am. J. Ophthalmol. 1987, 103:790-797.
58. 165 after subretinal adenoviral gene transfer in the rabbit. Mol. Vis. 2008, 14:1358-1372.
59. Kakehashi A., Saito Y., Mori K., Sugi N., Ono R., Yamagami H., Shinohara M., Tamemoto H., Ishikawa S., Kawakami M., Kanazawa Y. Characteristics of diabetic retinopathy in SDT rats. Diabetes Metab. Res. Rev. 2006, 22:455-461.
60. Kiilgaard J.F., Nis Andersen M.V., Wiencke A.K., et al. A new animal model of choroidal neovascularization. Acta Ophthalmol. Scand. 2005, 83:297-704.
61. Kilarski W.W.W., Samolov B., et al. Biochemical regulation of blood vessel growth during tissue vascularization. Nat. Med. 2009, 15:657-664.
62. Kimura H., Sakamoto T., Hinton D.R., et al. A new model of subretinal neovascularzation in the rabbit. Inv Ophthalmol. Vis. Sci. 1995, 36:2110-2119.
63. Kimura H., Spee C., Sakamoto T., et al. Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres. Inv Ophthalmol. Vis. Sci. 1999, 40:524-528.
64. Kvanta A., Algvere P.V., Berglin L., Seregard S. Subfoveal fibrovascualr membranes in age-related macular degeneration express vascular endothelial growth factor. Inv Ophthalmol. Vis. Sci. 1996, 37:1929-1934.
65. Kwak N., Okamoto N., Wood J.M., Campochiaro P.A. VEGF is major stimulator in model of choroidal neovascularization. Inv Ophthalmol. Vis. Sci. 2000, 41:3158-3164.
66. Lai C.M., Dunlop S.A., May L.A., et al. Generation of transgenic mice with mild and severe retinal neovascularisation. Br. J. Ophthalmol. 2005, 89:911-916.
67. Lassota N. Clinical and histological aspects of CNV formation: studies in an animal model. Acta Ophthalmologica 2008, 1-24.
68. Lassota N., Kiilgaard J., la Cour M., Scherfig E., Prause J.U. Natural history of chorodal neovascularization after surgical inducation in an animal model. Acta Ophthalmologica 2008, 86:295-503.
69. Lassota N., Kiilgaard J., Prause J.U., la Cour M. Correlation between clinical and histological features in a pig model of choroidal neovascularization. Graefe's Arch. Clin. Exp. Ophthalmol. 2006, 244:394-398.
70. Lassota N., Kiilgaard J., Prause J.U., et al. Surgical induction of choroidal neovascularization in a procine model. Graefe's Arch. Clin. Exp. Ophthalmol. 2007, 245:1189-1198.
71. Lopez P.F., Sippy B.D., Lambert H.M., et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically-excised age-related macular degeneration-related choroidal neovascular membranes. Inv Ophthalmol. Vis. Sci. 1996, 37:855-868.
72. Madan A., Penn J.S. Animal models of oxygen-induced retinopathy. Front. Biosci. 2003, 8:d1030-d1043.
73. Malek G., Johnson L.V., Mace B.E., et al. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. PNAS 2005, 102:11900-11905.
74. Masuzawa K., Jesmin S., Maeda S., Zaedi S., Shimojo N., Miyauchi T., et al. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina. Exp. Biol. Med. 2006, 231:1090-1094.
75. McLeod D.S., Brownstein R., Lutty G.A. Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 1996, 37:300-311.
76. McLeod D.S., D'Anna S.A., Lutty G.A. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy. Invest. Ophthalmol. Vis. Sci. 1998, 39:1918-1932.
77. Michaelson I.C. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases. Trans. Ophthalmol. Soc. UK 1948, 68:137-180.
78. Miller H., Miller B., Ryan S.J. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Inv Ophthalmol. Vis. Sci. 1986, 27:1644-1652.
79. Miller J.W. Vascular endothelial growth factor and ocular neovascularization. Am. J. Pathol. 1997, 151:13-23.
80. Mori K., Duh E., et al. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J. Cell Physiol. 2001, 188:253-263.
81. Mori K., Gelbach P., Yamamoto S., et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Inv Ophthalmol. Vis. Sci. 2002, 43:1994-2000.
82. Mullins R.F., Russell S.R., et al. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis and dense deposit disease. FASEB 2000, 14:835-846.
83. Ni M., Holland M., Jarstadmarken H., De Vries G. Time-course of experimental choroidal neovascularzation in Dutch-Belted rabbit: clinical and histological evaluation. Exp. Eye Res. 2005, 81:286-297.
84. Ohno-Matsui K., Hirose A., Yamamoto S., et al. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am. J. Pathol. 2002, 160:711-719.
85. Okamoto N., Tobe T., Hackett S.F., et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina. A new model of intraretinal and subretinal neovascularization. Am. J. Pathol. 1997, 151:281-291.
86. Oshima Y., Oshima S., Nambu H., et al. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J. Cell Physiol. 2004, 201:393-400.
87. Park K.H., Fridley B.L., Ryu E., et al. Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration. Inv Ophthalmol. Vis. Sci. 2009, 50:3386-3393.
88. Penfold P., Killingsworth M., Sarks S. An ulstrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. Aust. J. Ophthalmol. 1984, 12:23-31.
89. Penfold P.L., Madigan M.C., et al. Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res. 2001, 20:385-414.
90. Penn J.S., Rajaratnam V.S. Inhibition of retinal neovascularization by intravitreal injection of human rPAI-1 in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2003, 44:5423-5429.
91. Penn J.S., Rajaratnam V.S., Collier R.J., Clark A.F. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2001, 42:283-290.
92. Penn J.S., Tolman B.L., Lowery L.A. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest. Ophthalmol. Vis. Sci. 1993, 34:576-585.
93. Pournaras C.J., Tsacopoulos M., Strommer K., Gilodi N., Leuenberger P.M. Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology 1990, 97:1321-1328.
94. Qui G., Stewart J.M., Vas Sadda S., et al. A new model of experimental subretinal neovascularization in the rabbit. Exp. Eye Res. 2006, 83:141-142.
95. Rakic J.M., Lambert V., Munaut C., et al. Mice without upa, tpa or plasminigen genes are resistant to experimental choroidal neovascularization. Inv Ophthlamol Vis. Sci. 2003, 44:1732-1739.
96. Rakoczy P.E., Brankov M., Fonceca A., Zaknich T., Rae B.C., Lai C.M. Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy. Diabetes 2003, 52:857-863.
97. Rakoczy P.E., Yu M.J.T., Nusinowitz S., Chang B., Heckenlively J.R. Mouse models of age-related macular degeneration. Exp. Eye Res. 2006, 82:741-752.
98. Reich S.J., Fosnot J., Kuroki A., Tang W., Yang X., Maguire A.M., Bennett J., Tolentino M.J. Small interfering RNA (SiRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol. Vis. 2003, 9:210-216.
99. Ritter M.R., Banin E., Moreno S.K., Aguilar E., Dorrell M.I., Friedlander M. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J. Clin. Invest. 2006, 116:3266-3276.
100. Ryan S.R. Subretinal neovascularization. Natural history of an experimental model. Arch. Ophthalmol. 1982, 1804-1809.
101. Ryan S.J. The development of an experimental model of subretinal neovascualrization in disciform macular degeneration. Trans. Am. Ophthalmol. Soc. 1979, 127:707-745.
102. Saishin Y., Silva R.L., Saishin Y., et al. Periocular injection of micropsheres containing PKC412 inhibits choroidal neovascularization in a porcine model. Inv Ophthlmol Vis. Sci. 2003, 44:4989-4993.
103. Saito Y., Park L., Skolik S.A., et al. Experimental preretinal neovascularization by laser-induced venous thrombosis in rats. Curr. Eye Res. 1997, 16:26-33.
104. Sakamoto T., Sanui H., Ishibashi T., et al. Subretinal neovascularization in the rat induced by IRBP synthetic peptides. Exp. Eye Res. 1994, 58:155-160.
105. Sakurai E., Anand A., Ambati B.K., van Rooigen N., Ambati J. Macrophage depeletion inhibits experimental choroidal neovascularization. Inv Ophthalmol. Vis. Sci. 2003, 44:3578-3585.
106. Sarraf D. Diabetes and Eye Disease 2001, American Academy of Ophthalmology, San Francisco, CA, pp. 3-5, 8-20.
107. Schlingemann R.O. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 2004, 242:91-101.
108. Scholl H.P.N., Charbel I.P., Walier M., et al. Systemic complement activation in age-related macular degeneration. PLOS 2008, 3:e2593.
109. Schmack I., Berglin L., Nie X., et al. Modulation of choroidal neovascularization by subretinal injection of retinal pigment epithelium and polystyrene microbeads. Mol. Vis. 2009, 15:146-161.
110. Schwesinger C., Yee C., Rohan R.M., et al. Intrachoroidal neovascualrization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am. J. Pathol. 1994, 158:1161-1172.
111. Seo M.S., Kwak N., Ozaki H., et al. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am. J. Pathol. 1999, 154:1743-1753.
112. Sengupta N., Caballero S., Mames R.N., et al. The role of adult bone marrow-derived stem cells in choroidal neovascularuzation. Inv Ophthalmol. Vis. Sci. 2003, 44:4908-4913.
113. Shen W., He S., Han S., Ma Z. Preretinal neovascularisation induced by photodynamic venous thrombosis in pigmented rat. Aust. NZ. J. Ophthalmol. 1996, 24:50-52.
114. Shen D., Wen R., Tuo J., Bojanowski C.M., Chan C.C. Exacerbation of retinal degeneration and choroidal neovascularization by subretinal injection of Matrigel in CCL2/MCP-1-deficient mice. Ophthal Res. 2006, 38:71-73.
115. Shimizu K., Kobayashi Y., Muraoka K. Midperipheral fundus involvement in diabetic retinopathy. Ophthalmology 1981, 88:601-612.
116. Shinohara M., Masuyama T., Shoda T., Takahashi T., Katsuda Y., Komeda K., Kuroki M., Kakehashi A., Kanazawa Y. A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int. J. Exp. Diabetes Res. 2000, 1:89-100.
117. Singh S.R., Grossniklaus H.E., Kang S.J., et al. Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. Gene Ther. 2009, 16:645-659.
118. Smith L.E. Pathogenesis of retinopathy of prematurity. Acta Paediatr. Suppl. 2002, 91:26-28.
119. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., D'Amato P.A. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 1994, 35:101-111.
120. Smith R.S., John S.W.M., Zabeleta A., et al. The Bst locus on mouse chromosome 16 is associated with age-related subretinal neovascularization. PNAS 2000, 97:2191-2195.
121. Sosula L., Beaumont P., Hollows F.C., Jonson K.M. Dilatation and endothelial proliferation of retinal capillaries in streptozotocin-diabetic rats: quantitative electron microscopy. Invest. Ophthalmol. Vis. Sci. 1972, 11:926-935.
122. Sourbane G., Cohen S.Y., Delayer T., et al. Basic fibroblast growth factor experimentally induced choroidal angiogenesis. Curr. Eye Res. 1994, 13:183-195.
123. Spilsbury K., Garrett K.L., Shen W., et al. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularzation. Am. J. Pathol. 2000, 157:135-144.
124. Spraul C.W., Grossniklaus H.E. Characteristics of Drusen and Bruch's membrane in post-mortem eyes with age-related macular degeneration. Arch. Ophthalmol. 1997, 115:267-273.
125. Sven B., Sejersen S., Berglin L., Seregard S., Kvanta A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Inv Ophthalmol. Vis. Sci. 1998, 29:2194-2200.
126. Takahashi T., nakamura T., Hayashi A., Kamei M., Nakabayashi M., Okada A.A., Tomita T., Karenda Y., Tano Y. Inhibition of experimental choroidal neovasculaurization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells. Am. J. Ophthalmol. 2000, 130:774-781.
127. Takeda A., Baffi J.Z., Kleinman M.E., et al. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 2009, 460:225-231.
128. Tamai K., Spaide R., Ellis E.A., et al. Lipid hydroperoxide stimulates subretinal chorodal neovascularization in the rabbit. Exp. Eye Res. 2002, 74:301-308.
129. Tano Y., Chandler D.B., Machemer R. Retinal neovascularization after intravitreal fibroblast injection. Am. J. Ophthalmol. 1981, 92:103-109.
130. The Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema: early treatment diabetic retinopathy study report no. 4. Int. Ophthalmol. Clin. 1987, 27:265-272.
131. Tobe T., Okamoto N., Vinores M.A., et al. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Inv Ophthalmol. Vis. Sci. 1998, 39:180-188.
132. Tobe T., Ortega S., Luna J., et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am. J. Pathol. 1998, 153:141-1646.
133. Wada M., Ogata N., Otsuji T., Uyama M. Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization. Curr. Eye Res. 1999, 18:203-213.
134. Wang F., Rendahl K.G., Manning W.C., et al. AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. Invest. Ophthalmol. Vis. Sci. 2003, 44:781-790.
135. Yamada H., Yamada E., Higuchi A., Matsumura M. Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat. Diabetologia 2005, 48:1663-1668.
136. Yetemian, R.M., Brown, B.M., Craft, C.M., Loss of G-protein coupled receptor kinase in Nrl-/- mice leads to neovascularization, enhanced inflammatory response, and age-related cone dystrophy. Invest. Ophthalmol. Vis. Sci., in press.
137. Yanagi Y., tamaki Y., Obata R., Muranaka K., Humma N., Matsuoka H., Mano H. Subconjunctival administration of bucillamine suppresses choroidal neovascularization. Inv Ophthalmol. Vis. Sci. 2002, 43:3495-3499.
138. Zamiri P., Masli S., Streilein J.W., Taylor A.W. Pigment epithelial growth factor suppresses inflammation by modulating macrophage activity. Inv Ophthalmol. Vis. Sci. 2006, 47:3912-3918.
139. Zhan G., Vossmeyer D., Stragies R., et al. Preclinical evaluation of the new small-moleculae integrin alpha 5 beta 1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization. Arch. Ophthalmol. 2009, 127:1329-1335.
140. Zhang S.X., Sima J., Wang J.J., Shao C., Fant J., Ma J.X. Systemic and periocular deliveries of plasminogen kringle 5 reduce vascular leakage in rat models of oxygen-induced retinopathy and diabetes. Curr. Eye Res. 2005, 30:681-689.
141. Zhu Z.R., Goodnight R., Sorgente N., et al. Morphotoic observations of retinal pigment epithelial proliferation and neovascularization in the rabbit. Retina 1989, 9:319-327.